Mississippi · 2026 Regular Session · Bill
SB 2561: Ibogaine; authorize MSDH to select a consortium to conduct a drug development clinical trial to secure FDA's approval of.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 2561 is a bill introduced in the Mississippi Senate on January 19, 2026. According to its official title, it concerns: Ibogaine; authorize MSDH to select a consortium to conduct a drug development clinical trial to secure FDA's approval of. Primary sponsor: Josh Harkins (Republican). Most recent recorded action (February 3, 2026): Died In Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Josh Harkins | Primary sponsor | Republican | Senate | 20 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Died In Committee
- Referred To Public Health and Welfare